Clinical Trials Logo
  1. Home
  2. Basal Cell Nevus Syndrome
  3. NCT04308395

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Basal Cell Nevus Syndrome Clinical Trial

Official title:
A Phase 3, Multicenter, Open-Label Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Clinical Trial Summary

This is a multicenter, open label extension study evaluating the safety of Patidegib Topical Gel, 2%, applied topically twice daily to the face of adult subjects with Gorlin syndrome.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04308395
Study type Interventional
Source Sol-Gel Technologies, Ltd.
Contact
Status Terminated
Phase Phase 3
Start date June 3, 2020
Completion date July 14, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT02550678 - A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma Phase 1/Phase 2
Completed NCT00555633 - Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients N/A
Recruiting NCT03483441 - Vitamin D and Photodynamic Therapy for Treatment of BCC in BCNS Phase 1
Active, not recruiting NCT03467789 - Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma Phase 1
Recruiting NCT05463757 - Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study
Completed NCT02762084 - Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients Phase 2
Withdrawn NCT03767439 - Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome Phase 2
Completed NCT04416516 - Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor Phase 2
Recruiting NCT06330350 - Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Enrolling by invitation NCT06330324 - Reproductive Options in Inherited Skin Diseases
Terminated NCT02303041 - Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma Phase 2
Completed NCT02100371 - Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome N/A
Completed NCT03703310 - Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome) Phase 3
Completed NCT02157623 - Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome N/A
Completed NCT00957229 - To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) Phase 2
Completed NCT01556009 - Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas Phase 2